PD-L1, as an immunoinhibitory molecule that inhibits T cell-mediated immune responses, is mainly expressed on the surface of tumor cells and antigen-presenting cells in various solid malignancies including lung cancer16,17. The gene discussed is CD274; the disease is neoplasm.